Saurabh Saxena

Saurabh Saxena

Auto-generated profile, based on publicly available information

Saurabh Saxena

DSS Takara Bio India Pvt Ltd

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2010 in Acta Physiologica
Verified
Journal Article
Closed access
PDF file
SSS. Saxena
S. Saxena
DSD. Shukla
D. Shukla
YKY. A. Khan
Y. A. Khan
MSM. Singh
M. Singh
ABA. Bansal
A. Bansal
SJS. K. Jain
S. K. Jain

1 April 2011 in European Journal of Pharmacology
Verified
Journal Article
Closed access
DSDhananjay Shukla
Dhananjay Shukla
SSSaurabh Saxena
Saurabh Saxena
JPJayamurthy Purushothaman
Jayamurthy Purushothaman
KSKalpana Shrivastava
Kalpana Shrivastava
MSMrinalini Singh
Mrinalini Singh
ABAnju Bansal
Anju Bansal

14 July 2011 in Functional & Integrative Genomics
Verified
Journal Article
Closed access
PDF file
YAYasmin Ahmad
Yasmin Ahmad
DSDhananjay Shukla
Dhananjay Shukla
IGIti Garg
Iti Garg
NSNarendra Kumar Sharma
Narendra Kumar Sharma
SSSaurabh Saxena
Saurabh Saxena
KBKalpana Bhargava
Kalpana Bhargava

1 November 2012 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
SSSaurabh Saxena
Saurabh Saxena
DSDhananjay Shukla
Dhananjay Shukla
ABAnju Bansal
Anju Bansal

1 March 2009 in High Altitude Medicine & Biology
Verified
Journal Article
Closed access
DSDhananjay Shukla
Dhananjay Shukla
SSSaurabh Saxena
Saurabh Saxena
PJPurushotman Jayamurthy
Purushotman Jayamurthy
MSMustoori Sairam
Mustoori Sairam
MSMrinalini Singh
Mrinalini Singh
GIGovindaswamy Ilavazaghan
Govindaswamy Ilavazaghan
Shukla, Dhananjay, Saurabh Saxena, Purushotman Jayamurthy, Mustoori Sairam, Mrinalini, Singh, Swatantra Kumar Jain, Anju Bansal, and Govindaswamy Ilavazaghan. High Alt. Med. Biol. 10:57–69, 2009.—Hypoxic preconditioning (HPC) provides robust protection against injury from subsequent prolonged hypobaric hypoxia, which is a characteristic of high altitude and is known to induce oxidative injury in lung by increasing the generation of reactive oxygen species (ROS) and decreasing the effectiveness of the antioxidant defense system. We hypothesize that HPC with cobalt might protect the lung from subsequent hypobaric hypoxia-induced lung injury. HPC with cobalt can be achieved by oral feeding of CoCl2 (12.5 mg kg−1) in rats for 7 days. Nonpreconditioned rats responded to hypobaric hypoxia (7619 m) by increased reactive oxygen species (ROS) generation and a decreased GSH/GSSG ratio. They also showed a marked increase in lipid peroxidation, heat-shock proteins (HSP32, HSP70), metallothionins (MT), levels of inflammatory cytokines (TNF-α, IFN-γ, MCP-1), and SOD, GPx, and GST enzyme activity. In contrast, rats preconditioned with cobalt were far less impaired by severe hypobaric hypoxia, as observed by decreased ROS generation, lipid peroxidation, and inflammatory cytokine release and an inceased GSH/GSSG ratio. Increased expression of antioxidative proeins Nrf-1, HSP-32, and MT was also observed in cobalt-preconditioned animals. A marked increase in the protein expression and DNA binding activity of hypoxia-inducible transcriptional factor (HIF-1α) and its regulated genes, such as erythropoietin (EPO) and glucose transporter-1 (glut-1), was observed after HPC with cobalt. We conclude that HPC with cobalt enhances antioxidant status in the lung and protects from subsequent hypobaric hypoxia-induced oxidative stress.

1 December 2010 in Journal of Pharmacy and Pharmacology
Verified
Journal Article
Closed access
PDF file
MSMrinalini Singh
Mrinalini Singh
DSDhananjay Shukla
Dhananjay Shukla
PTPauline Thomas
Pauline Thomas
SSSaurabh Saxena
Saurabh Saxena
ABAnju Bansal
Anju Bansal